Glydo
Glydo is a pharmaceutical product offered by SAGENT Pharmaceuticals, providing GLYDO (lidocaine HCl jelly, USP) 2%, a sterile, prefilled urological anesthetic lubricant designed for topical administration. The product is available in 6 mL and 11 mL single-dose prefilled syringes, featuring a proprietary prefilled syringe technology called Uro*Fit*Tip™ developed by urologists for urethral procedures. GLYDO is used for prevention and control of pain in procedures involving the male and female urethra, topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation. It offers a differentiated and preferred feature set compared to other instillation products, with over 500 million applications in 40 countries and 40 years of experience. The product is designed for healthcare professionals, emphasizing patient comfort, clinical efficiency, and safety with detailed dosage and administration guidelines. The business model is pharmaceutical product sales through healthcare channels, with manufacturing by Klosterfrau Berlin GmbH and distribution by SAGENT Pharmaceuticals in the USA.
Glydo
Glydo is a pharmaceutical product offered by SAGENT Pharmaceuticals, providing GLYDO (lidocaine HCl jelly, USP) 2%, a sterile, prefilled urological anesthetic lubricant designed for topical administration. The product is available in 6 mL and 11 mL single-dose prefilled syringes, featuring a proprietary prefilled syringe technology called Uro*Fit*Tip™ developed by urologists for urethral procedures. GLYDO is used for prevention and control of pain in procedures involving the male and female urethra, topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation. It offers a differentiated and preferred feature set compared to other instillation products, with over 500 million applications in 40 countries and 40 years of experience. The product is designed for healthcare professionals, emphasizing patient comfort, clinical efficiency, and safety with detailed dosage and administration guidelines. The business model is pharmaceutical product sales through healthcare channels, with manufacturing by Klosterfrau Berlin GmbH and distribution by SAGENT Pharmaceuticals in the USA.